BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ashmore-Harris C, Iafrate M, Saleem A, Fruhwirth GO. Non-invasive Reporter Gene Imaging of Cell Therapies, including T Cells and Stem Cells. Mol Ther 2020;28:1392-416. [PMID: 32243834 DOI: 10.1016/j.ymthe.2020.03.016] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 14.0] [Reference Citation Analysis]
Number Citing Articles
1 Helfer BM, Ponomarev V, Patrick PS, Blower PJ, Feitel A, Fruhwirth GO, Jackman S, Pereira Mouriès L, Park MVDZ, Srinivas M, Stuckey DJ, Thu MS, van den Hoorn T, Herberts CA, Shingleton WD. Options for imaging cellular therapeutics in vivo: a multi-stakeholder perspective. Cytotherapy 2021;23:757-73. [PMID: 33832818 DOI: 10.1016/j.jcyt.2021.02.005] [Reference Citation Analysis]
2 Wardell CM, MacDonald KN, Levings MK, Cook L. Cross talk between human regulatory T cells and antigen-presenting cells: Lessons for clinical applications. Eur J Immunol 2021;51:27-38. [PMID: 33301176 DOI: 10.1002/eji.202048746] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
3 Goud NS, Bhattacharya A, Joshi RK, Nagaraj C, Bharath RD, Kumar P. Carbon-11: Radiochemistry and Target-Based PET Molecular Imaging Applications in Oncology, Cardiology, and Neurology. J Med Chem 2021;64:1223-59. [PMID: 33499603 DOI: 10.1021/acs.jmedchem.0c01053] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Lee SB, Ji HD, Lee IK, Kim KS, Lee J, Lee SW, Jeon YH. Visualization of platelet recruitment to tumor lesions using highly sensitive and stable radioiodine studded gold nanoprobes. J Mater Chem B 2021;9:2931-6. [PMID: 33885648 DOI: 10.1039/d0tb02265a] [Reference Citation Analysis]
5 Lechermann LM, Lau D, Attili B, Aloj L, Gallagher FA. In Vivo Cell Tracking Using PET: Opportunities and Challenges for Clinical Translation in Oncology. Cancers (Basel) 2021;13:4042. [PMID: 34439195 DOI: 10.3390/cancers13164042] [Reference Citation Analysis]
6 Kurebayashi Y, Choyke PL, Sato N. Imaging of cell-based therapy using 89Zr-oxine ex vivo cell labeling for positron emission tomography. Nanotheranostics 2021;5:27-35. [PMID: 33391973 DOI: 10.7150/ntno.51391] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
7 Jacob J, Nadkarni S, Volpe A, Peng Q, Tung SL, Hannen RF, Mohseni YR, Scotta C, Marelli-Berg FM, Lechler RI, Smyth LA, Fruhwirth GO, Lombardi G. Spatiotemporal in vivo tracking of polyclonal human regulatory T cells (Tregs) reveals a role for innate immune cells in Treg transplant recruitment. Mol Ther Methods Clin Dev 2021;20:324-36. [PMID: 33511246 DOI: 10.1016/j.omtm.2020.12.003] [Reference Citation Analysis]
8 Shao F, Long Y, Ji H, Jiang D, Lei P, Lan X. Radionuclide-based molecular imaging allows CAR-T cellular visualization and therapeutic monitoring. Theranostics 2021;11:6800-17. [PMID: 34093854 DOI: 10.7150/thno.56989] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
9 Mohseni YR, Tung SL, Dudreuilh C, Lechler RI, Fruhwirth GO, Lombardi G. The Future of Regulatory T Cell Therapy: Promises and Challenges of Implementing CAR Technology. Front Immunol 2020;11:1608. [PMID: 32793236 DOI: 10.3389/fimmu.2020.01608] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 15.0] [Reference Citation Analysis]
10 Lu D, Wang Y, Zhang T, Wang F, Li K, Zhou S, Zhu H, Yang Z, Liu Z. Metabolic radiolabeling and in vivo PET imaging of cytotoxic T lymphocytes to guide combination adoptive cell transfer cancer therapy. J Nanobiotechnology 2021;19:175. [PMID: 34112200 DOI: 10.1186/s12951-021-00924-2] [Reference Citation Analysis]
11 Volpe A, Lang C, Lim L, Man F, Kurtys E, Ashmore-Harris C, Johnson P, Skourti E, de Rosales RTM, Fruhwirth GO. Spatiotemporal PET Imaging Reveals Differences in CAR-T Tumor Retention in Triple-Negative Breast Cancer Models. Mol Ther 2020;28:2271-85. [PMID: 32645298 DOI: 10.1016/j.ymthe.2020.06.028] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 10.0] [Reference Citation Analysis]
12 Stark HL, Wang HC, Kuburic J, Alzhrani A, Hester J, Issa F. Immune Monitoring for Advanced Cell Therapy Trials in Transplantation: Which Assays and When? Front Immunol 2021;12:664244. [PMID: 33841448 DOI: 10.3389/fimmu.2021.664244] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
13 Schäfer R, Schwab M, Siegel G, von Ameln-Mayerhofer A, Buadze M, Lourhmati A, Wendel HP, Kluba T, Krueger MA, Calaminus C, Scheer E, Dominici M, Grisendi G, Doeppner TR, Schlechter J, Finzel AK, Gross D, Klaffschenkel R, Gehring FK, Spohn G, Kretschmer A, Bieback K, Krämer-Albers EM, Barth K, Eckert A, Elser S, Schmehl J, Claussen CD, Seifried E, Hermann DM, Northoff H, Danielyan L. Modulating endothelial adhesion and migration impacts stem cell therapies efficacy. EBioMedicine 2020;60:102987. [PMID: 32942121 DOI: 10.1016/j.ebiom.2020.102987] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
14 Witney TH, Blower PJ. The chemical tool-kit for molecular imaging with radionuclides in the age of targeted and immune therapy. Cancer Imaging 2021;21:18. [PMID: 33516256 DOI: 10.1186/s40644-021-00385-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]